Institutional investors purchased a net $29.6 million shares of NVO during the quarter ended December 2016, and now own 7.75% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LOOMIS, SAYLES & CO. LP Bought 3.9 Million shares of Novo Nordisk
TWO SIGMA ADVISERS LP Bought 2.7 Million shares of Novo Nordisk
SUSTAINABLE GROWTH ADVISERS LP Bought 1.6 Million shares of Novo Nordisk